MetaCap

Collegium Pharmaceutical Inc. Company Profile

NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

24.72-0.49 (-1.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Collegium Pharmaceutical at a glance

Collegium Pharmaceutical Inc. (NASDAQ: COLL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Stoughton, MA. Collegium Pharmaceutical is led by Mr. Vikram Karnani and employs about 423 people. The company's shares have traded publicly since 2015.

At a market capitalization of $783.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001267565, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Collegium Pharmaceutical do?

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Collegium Pharmaceutical Inc.
Ticker
NASDAQ: COLL
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Vikram Karnani
Employees
423
Headquarters
100 Technology Center Drive, Stoughton, MA, United States
Phone
781 713 3699
IPO year
2015
Market cap
$783.41M
SEC CIK
0001267565
Latest annual report
10-K · Feb 26, 2026

Companies similar to Collegium Pharmaceutical

COLL peer companies
CompanyPrice% ChgMarket capCompare
SNDXSyndax Pharmaceuticals Inc.8.72-4.49%$785.05Mvs COLL
IRWDIronwood Pharmaceuticals Inc. Class A4.70-0.21%$778.09Mvs COLL
VSTMVerastem Inc.6.33-7.73%$797.67Mvs COLL
ORICOric Pharmaceuticals Inc.7.36-4.42%$764.94Mvs COLL
RIGLRigel Pharmaceuticals Inc.40.09-2.67%$754.89Mvs COLL
ARDXArdelyx Inc.2.99-2.29%$751.60Mvs COLL
CRVSCorvus Pharmaceuticals Inc.9.67-3.40%$815.69Mvs COLL
IVAInventiva S.A. American Depository Shares3.14-8.99%$750.78Mvs COLL

Related